CD274 and neoplasm: Compared with the Ad-CAIX-treated group, Ad-CAIX/Ad-PD-L1-treated group exhibited that the growth of subcutaneous tumors was inhibited (Fig. 1b), and the tumor volume was significantly reduced (Fig. 1c).